Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia.
D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002648:Child; D002675:Child, Preschool; D004361:Drug Tolerance; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000401:mortality; D007970:Leukopenia / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced
D000903:Antibiotics, Antineoplastic